文献速递中枢神经肿瘤放疗

预测颞叶胶质母细胞瘤的失败模式:对放疗照射野的可能影响

Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals.
PubMed 文献 · Radiat Oncol · 2018-07-20

研究纳入2007年3月至2014年7月间接受放疗的335例胶质母细胞瘤患者,其中100例位于颞叶。分析初诊和复发时肿瘤位置与颞叶解剖及神经通路的关系,发现多数失败发生在局部或邻近区域,且复发模式与初始颞叶部位相关,超过半数涉及神经通路。

要点

  • 100例颞叶胶质母细胞瘤患者中,86例出现影像学进展,中位生存期17.3个月。
  • 首次复发时局部区域失败率为74%,远处失败率为26%,53%患者有神经通路受累。
  • 初始肿瘤位置可预测局部复发(p<0.0001)、区域复发(p=0.004)和神经通路复发模式(p=0.005),但不能预测远处失败(p=0.081)。

核心结论

  • 多数胶质母细胞瘤在局部或邻近区域失败,复发模式可预测且与初始颞叶部位相关,超过半数涉及神经通路。
  • 了解肿瘤浸润和失败模式可能改善靶区定义和放疗。

研究设计与样本

  • 研究分析了2007年3月至2014年7月间接受放疗的335例胶质母细胞瘤患者,其中100例位于颞叶。
  • 将初始肿瘤部位和后续复发部位细分为5个局部颞叶部位、5个邻近区域部位和5个远处失败部位。
  • 沿主要神经解剖通路的延伸在初诊和首次影像学失败时分为前、上、内和后通路。

主要发现

  • 100例患者中86例出现影像学进展,中位生存期17.3个月。
  • 初诊时74%的肿瘤与一个颞叶部位相关,94%局限于颞叶,19%在治疗前MRI有神经通路病变。
  • 首次复发时局部区域失败率为74%,26%失败于远处部位,53%患者有神经通路受累。
  • 初始肿瘤位置可预测局部部位复发(p<0.0001)、区域部位复发(p=0.004)和神经通路复发模式(p=0.005),但不能预测远处部位失败(p=0.081)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Characterise patterns of failure of Temporal Lobe (TL) Glioblastoma (GBM) following treatment with relation to normal temporal lobe anatomy and neural pathways. METHODS: 335 GBM patients received radiotherapy between 03/2007 and 07/2014, 100 were located in TL. Site of initial tumour and subsequent relapse were subdivided into 5 local TL sites (anterior, lateral, medial, posterior and superior); 5 adjacent regional sites (occipital lobe, inferior frontal lobe, caudate/thalamus/internal/external capsules, fornix/ventricular trigone), and 5 distant failure sites (ventricles, contralateral hemisphere, brainstem, leptomeninges and spine). Extension along major neuroanatomical pathways at initial presentation and at first documented Magnetic Resonance Imaging (MRI) failure were categorised into anterior, superior, medial and posterior pathways. RESULTS: Of the 100 patients, 86 had radiological progress with a median survival of 17.3 months. At initial diagnosis, 74% of tumours were linked to one TL site and 94% were confined to the TL. 19% had neural pathway disease at initial pre-treatment MRI. At first recurrence locoregional site failure was 74%. 26% failed within distant sites and 53% patients were noted to have neural pathway involvement. Initial tumour location predicted for local site recurrence (p < 0.0001), regional site recurrence (p = 0.004) and neural pathway recurrence pattern (p = 0.005), but not for distant sites (p = 0.081). CONCLUSION: Most GBMs fail at local or adjacent regional sites. Many of the recurrences occurred in a predictable pattern within a local or regional site, unique to initial TL site with more than half involving neural pathways. Knowledge of tumour infiltration and failure may improve target definition and radiotherapy.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Jayamanne D, Wheeler H, Brazier D, et al. Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals. Radiat Oncol. 2018. PMID: 30029668. doi:10.1186/s13014-018-1078-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。